The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data…
FDA reviewing safety of abortion drug mifepristone
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Vance hosted GOP senators for dinner following Iran blow up
Administration Vance hosted GOP senators for dinner following Iran blow up Comments: by Julia Manchester - 06/25/26 1:52...
Van Hollen joins Sanders in endorsing El-Sayed in Michigan Senate primary
Campaign Van Hollen joins Sanders in endorsing El-Sayed in Michigan Senate primary Comments: by Max Rego - 06/25/26 1:41...
Don’t pull apart what’s finally working to curb overdose deaths
Opinion>Opinions - Healthcare The views expressed by contributors are their own and not the view of The Hill Don’t pu...
Mullin confronts DeLauro at hearing: ‘You should be put in your place’
House Mullin confronts DeLauro at hearing: ‘You should be put in your place’ Comments: by Ashleigh Fields - 06/25/26 1:2...